L. Kópper

1.9k total citations · 1 hit paper
39 papers, 1.5k citations indexed

About

L. Kópper is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, L. Kópper has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in L. Kópper's work include Glycosylation and Glycoproteins Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Cancer Research and Treatments (5 papers). L. Kópper is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Cancer Research and Treatments (5 papers). L. Kópper collaborates with scholars based in Hungary, United States and Italy. L. Kópper's co-authors include Generoso Bevilacqua, Patricia S. Steeg, Unnur P. Thorgeirsson, James E. Talmadge, Mark E. Sobel, Lance A. Liotta, K. Lapis, Rudolf Mihalik, Ágota Szepesi and András Matolcsy and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cell Death and Differentiation and European Journal of Cancer.

In The Last Decade

L. Kópper

37 papers receiving 1.5k citations

Hit Papers

Evidence for a Novel Gene Associated With Low Tumor Metas... 1988 2026 2000 2013 1988 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Kópper Hungary 12 1.2k 617 336 264 147 39 1.5k
Mathieu Boissan France 25 1.3k 1.1× 393 0.6× 319 0.9× 196 0.7× 169 1.1× 52 1.9k
P. S. Steeg United States 9 1.6k 1.4× 703 1.1× 378 1.1× 394 1.5× 271 1.8× 13 1.8k
Douglas Halverson United States 14 720 0.6× 197 0.3× 531 1.6× 256 1.0× 129 0.9× 18 1.2k
M Mabry United States 18 835 0.7× 232 0.4× 667 2.0× 284 1.1× 266 1.8× 26 1.5k
Jessica Adickes United States 4 1.4k 1.2× 191 0.3× 548 1.6× 102 0.4× 140 1.0× 4 1.9k
Yuji Basaki Japan 20 1.1k 0.9× 218 0.4× 540 1.6× 295 1.1× 214 1.5× 27 1.5k
A Nehmé United States 13 710 0.6× 430 0.7× 643 1.9× 93 0.4× 267 1.8× 15 1.3k
Melanie T. Hartsough United States 11 933 0.8× 320 0.5× 253 0.8× 104 0.4× 103 0.7× 11 1.1k
Gretchen M. Unger United States 17 1.2k 1.0× 115 0.2× 438 1.3× 83 0.3× 181 1.2× 29 1.6k
Gennaro Colella Italy 16 800 0.7× 122 0.2× 439 1.3× 94 0.4× 154 1.0× 29 1.1k

Countries citing papers authored by L. Kópper

Since Specialization
Citations

This map shows the geographic impact of L. Kópper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Kópper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Kópper more than expected).

Fields of papers citing papers by L. Kópper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Kópper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Kópper. The network helps show where L. Kópper may publish in the future.

Co-authorship network of co-authors of L. Kópper

This figure shows the co-authorship network connecting the top 25 collaborators of L. Kópper. A scholar is included among the top collaborators of L. Kópper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Kópper. L. Kópper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Csernus, Balázs, Csaba Bödör, Ágota Szepesi, et al.. (2005). Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia. 19(9). 1656–1662. 29 indexed citations
3.
Mihalik, Rudolf, Gergely Imre, István Peták, B. Szende, & L. Kópper. (2004). Cathepsin B-independent abrogation of cell death by CA-074-OMe upstream of lysosomal breakdown. Cell Death and Differentiation. 11(12). 1357–1360. 27 indexed citations
4.
Tímár, Botond, Zsolt Zoltán Fülöp, Balázs Csernus, et al.. (2003). Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia. 18(2). 326–330. 33 indexed citations
5.
Tı́már, József, Erzsébet Rásó, Sándor Paku, & L. Kópper. (1998). Oral administration of a trace element preparation and zinc inhibit liver metastasis of 3LL-HH murine tumor cells.. International Journal of Molecular Medicine. 2(1). 105–8. 9 indexed citations
6.
Sebestyén, Anna, Ilona Kovalszky, Rudolf Mihalik, et al.. (1997). Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia. European Journal of Cancer. 33(13). 2273–2277. 22 indexed citations
7.
Sebestyén, Anna, Rudolf Mihalik, István Peták, & L. Kópper. (1997). Modulation of apoptosis signaling in etoposide-treated lymphoma cells.. PubMed. 17(4A). 2609–14. 11 indexed citations
8.
Kópper, L., K. Lapis, Zsuzsa Schaff, & Rudolf Mihalik. (1993). Significance of cellular DNA content in human liver tumors.. PubMed. 64(5-6). 165–9. 1 indexed citations
9.
Török, Nicholas, et al.. (1991). Expression of Transforming Growth Factor-Beta 1 in Human Non-Hodgkin's Lymphoma Xenografts. JNCI Journal of the National Cancer Institute. 83(16). 1174–1175. 1 indexed citations
10.
Kópper, L., József Tı́már, Ilona Kovalszky, Csaba Fülöp, & Tibor T. Glant. (1991). Epitopes of cartilage core proteins and GAG pattern in human non-Hodgkin lymphoma xenografts.. PubMed. 4(2). 149–52. 1 indexed citations
11.
Süli‐Vargha, Helga, A. Jéney, L. Kópper, et al.. (1990). Investigations on the antitumor effect and mutagenicity of α-MSH fragments containing melphalan. Cancer Letters. 54(3). 157–162. 3 indexed citations
12.
Steeg, Patricia S., Generoso Bevilacqua, L. Kópper, et al.. (1988). Evidence for a Novel Gene Associated With Low Tumor Metastatic Potential. JNCI Journal of the National Cancer Institute. 80(3). 200–204. 1125 indexed citations breakdown →
13.
Kópper, L., et al.. (1988). Phenotypic characteristics of three human non-Hodgkin lymphoma lines: flow cytometric analysis after long-term maintenance.. PubMed. 74(2). 295–9. 6 indexed citations
14.
15.
Kópper, L. & K. Lapis. (1985). What's New in Macrophage-Tumor Cell Interaction?. Pathology - Research and Practice. 179(6). 652–655. 5 indexed citations
17.
Kópper, L., et al.. (1984). Renal Cell Carcinoma – Xenotransplantation into Immunosuppressed Mice. Oncology. 41(1). 19–24. 2 indexed citations
18.
Tı́már, József, L. Kópper, Kamalesh Pal, & K. Lapis. (1983). Transmission and Scanning-Electronmicroscopy of Experimental Liver Metastases Derived from Intrasplenically Growing Primary Tumor. Pathology - Research and Practice. 177(1). 47–59. 6 indexed citations
19.
Takács, J., et al.. (1981). Ultrastructure of human colorectal tumour xenografts maintained serially in immunosuppressed mice.. PubMed. 29(2-3). 141–59. 1 indexed citations
20.
Kópper, L., et al.. (1971). Examination of the tumour growth promoting effect of -N-trimethyllysine. An autoradiographic study.. PubMed. 18(3). 251–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026